Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
Clinical trial NCT01593475 · COMPLETED
Trial details
- NCT number
- NCT01593475
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-05
- Primary completion
- 2016-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.